195 related articles for article (PubMed ID: 16300630)
1. Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42.
Leuchtenberger S; Kummer MP; Kukar T; Czirr E; Teusch N; Sagi SA; Berdeaux R; Pietrzik CU; Ladd TB; Golde TE; Koo EH; Weggen S
J Neurochem; 2006 Jan; 96(2):355-65. PubMed ID: 16300630
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein.
Irizarry MC; Deng A; Lleo A; Berezovska O; Von Arnim CA; Martin-Rehrmann M; Manelli A; LaDu MJ; Hyman BT; Rebeck GW
J Neurochem; 2004 Sep; 90(5):1132-43. PubMed ID: 15312168
[TBL] [Abstract][Full Text] [Related]
3. Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production.
Kukar T; Murphy MP; Eriksen JL; Sagi SA; Weggen S; Smith TE; Ladd T; Khan MA; Kache R; Beard J; Dodson M; Merit S; Ozols VV; Anastasiadis PZ; Das P; Fauq A; Koo EH; Golde TE
Nat Med; 2005 May; 11(5):545-50. PubMed ID: 15834426
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs lower Abeta42 and change presenilin 1 conformation.
Lleó A; Berezovska O; Herl L; Raju S; Deng A; Bacskai BJ; Frosch MP; Irizarry M; Hyman BT
Nat Med; 2004 Oct; 10(10):1065-6. PubMed ID: 15448688
[TBL] [Abstract][Full Text] [Related]
5. Truncated carboxyl-terminal fragments of beta-amyloid precursor protein are processed to amyloid beta-proteins 40 and 42.
Funamoto S; Morishima-Kawashima M; Tanimura Y; Hirotani N; Saido TC; Ihara Y
Biochemistry; 2004 Oct; 43(42):13532-40. PubMed ID: 15491160
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho.
Zhou Y; Su Y; Li B; Liu F; Ryder JW; Wu X; Gonzalez-DeWhitt PA; Gelfanova V; Hale JE; May PC; Paul SM; Ni B
Science; 2003 Nov; 302(5648):1215-7. PubMed ID: 14615541
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.
Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N
Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948
[TBL] [Abstract][Full Text] [Related]
8. Distinct mechanisms by mutant presenilin 1 and 2 leading to increased intracellular levels of amyloid beta-protein 42 in Chinese hamster ovary cells.
Qi Y; Morishima-Kawashima M; Sato T; Mitsumori R; Ihara Y
Biochemistry; 2003 Feb; 42(4):1042-52. PubMed ID: 12549925
[TBL] [Abstract][Full Text] [Related]
9. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
[TBL] [Abstract][Full Text] [Related]
10. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
Weggen S; Eriksen JL; Das P; Sagi SA; Wang R; Pietrzik CU; Findlay KA; Smith TE; Murphy MP; Bulter T; Kang DE; Marquez-Sterling N; Golde TE; Koo EH
Nature; 2001 Nov; 414(6860):212-6. PubMed ID: 11700559
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation amyloid beta-protein 42 production by interfering with transcript of presenilin 1 gene with siRNA.
Luo HM; Deng H; Xiao F; Gao Q; Weng W; Zhang PF; Li XG
Acta Pharmacol Sin; 2004 Dec; 25(12):1613-8. PubMed ID: 15569405
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Abeta production by NF-kappaB inhibitors.
Paris D; Patel N; Quadros A; Linan M; Bakshi P; Ait-Ghezala G; Mullan M
Neurosci Lett; 2007 Mar; 415(1):11-6. PubMed ID: 17223266
[TBL] [Abstract][Full Text] [Related]
15. Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain.
Weggen S; Eriksen JL; Sagi SA; Pietrzik CU; Golde TE; Koo EH
J Biol Chem; 2003 Aug; 278(33):30748-54. PubMed ID: 12777371
[TBL] [Abstract][Full Text] [Related]
16. Conserved residues within the putative active site of gamma-secretase differentially influence enzyme activity and inhibitor binding.
Wrigley JD; Nunn EJ; Nyabi O; Clarke EE; Hunt P; Nadin A; De Strooper B; Shearman MS; Beher D
J Neurochem; 2004 Sep; 90(6):1312-20. PubMed ID: 15341515
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease: channeling APP to non-amyloidogenic processing.
Tang BL
Biochem Biophys Res Commun; 2005 Jun; 331(2):375-8. PubMed ID: 15850769
[TBL] [Abstract][Full Text] [Related]
18. The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice.
Asai M; Hattori C; Iwata N; Saido TC; Sasagawa N; Szabó B; Hashimoto Y; Maruyama K; Tanuma S; Kiso Y; Ishiura S
J Neurochem; 2006 Jan; 96(2):533-40. PubMed ID: 16336629
[TBL] [Abstract][Full Text] [Related]
19. Gamma-secretase activity is present in rafts but is not cholesterol-dependent.
Wada S; Morishima-Kawashima M; Qi Y; Misono H; Shimada Y; Ohno-Iwashita Y; Ihara Y
Biochemistry; 2003 Dec; 42(47):13977-86. PubMed ID: 14636066
[TBL] [Abstract][Full Text] [Related]
20. Effects of sulindac sulfide on the membrane architecture and the activity of gamma-secretase.
Gamerdinger M; Clement AB; Behl C
Neuropharmacology; 2008 May; 54(6):998-1005. PubMed ID: 18359496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
